Daptomycin Versus Placebo in Patients With Neutropenia and Fever

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Febrile Neutropenia

In brief

The purpose of this study is to evaluate the benefits and side effects of daptomycin compared to placebo for the treatment of neutropenic fever.

Key facts

Study ID
NCT01216241
Run by
University of Rochester
People needed
36
Starts
2011-04-01
Expected to finish
2013-04-01
Last updated by the study team
2014-04-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.